SAN FRANCISCO, May 07, 2020 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -25.00% and 0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
David Newman no longer wears a tie to work. “We thought that telemedicine would be a burden, but it hasn’t been,” says Newman, 39, an endocrinologist at Sanford Health. The coronavirus epidemic is catapulting telemedicine from the outskirts of health care to its core.
Global Kinetics Pty Ltd., a digital health company focused on the development and commercialization of the Personal KinetiGraph® (PKG®), the first FDA-cleared and CE-marked platform for the objective measurement of movement symptoms in the management of Parkinson’s disease, today announced the appointment of Matthew C. Garrett, an experienced financial executive in the life sciences industry, as an independent director to its Board of Directors. “We are delighted to welcome Matt to our Board,” said John Schellhorn, CEO of Global Kinetics Corporation.
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN FRANCISCO, Feb. 10, 2020 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today.
SAN FRANCISCO, April 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced its virtual platform to support patients and clinicians in the wake of COVID-19 by offering home enrollment for the company’s Zio XT and Zio AT heart monitoring devices. Since patients with heart conditions are a particularly vulnerable population for COVID-19 and should avoid unnecessary visits to a doctor’s office, they can receive and apply the device from the comfort of their homes.
SAN FRANCISCO, Feb. 27, 2020 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pomerantz LLP is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (IRTC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether iRhythm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April 23, 2020. Ms. Budig was appointed as a Class II director and will also serve on the Audit Committee. “On behalf of the iRhythm team, I am delighted to welcome Renee to our Board of Directors,” said Kevin King, CEO.
Alex Ely outperforms his fund’s benchmark by selecting companies that meet his ‘better, cheaper, faster’ mantra.
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ladies and gentlemen, thank you for standing by, and welcome to the iRhythm Technologies, Inc. Q1 2020 earnings conference call. Joining me are Kevin King, CEO; Matthew Garrett, CFO; and Dan Wilson, EVP, strategy, corporate development and investor relations. Earlier today, iRhythm released financial results for the first quarter ended March 31, 2020.
iRhythm Technologies, Inc. (NASDAQ:IRTC) came out with its annual results last week, and we wanted to see how the...
SAN FRANCISCO, April 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the first quarter 2020 after the close of trading on Thursday, May 7, 2020. iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed.
SAN FRANCISCO, April 09, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today provided an update on the impact the company is experiencing due to the COVID-19 pandemic and the steps the company is taking in response. The company is also providing a preliminary range for revenue for its first quarter 2020 and is withdrawing full-year 2020 guidance. “The COVID-19 pandemic has been an unprecedented challenge to the healthcare community and our society,” said Kevin King, CEO.